Two of a Kind: The Property Brothers on their meteoric rise to television royalty status
Drew and Jonathan Scott are household names, known for their playful banter, attention to detail and commitment to quality on the home renovation projects they film for television shows such as Property Brothers , Celebrity IOU and Brother vs. Brother . The 47-year-old identical twins — Jonathan, a licensed contractor, and Drew, a real estate agent — didn't set out to become the most famous siblings in the home improvement industry. Still, they have embraced the journey and sit at the helm of what could easily be termed an empire, with a production company, multiple lines of home furnishings and décor and even a children's book series called Builder Brothers .
Firm Foundations
The twins got their start in Calgary, Alberta. 'We grew up on a ranch, and we were always handy. So, we decided right out of high school to start renovating houses to make money to go after our creative endeavors,' says Drew, who set his sights on being an actor and director.
'We bought a $500 infomercial course that promised you to 'make millions with no money down.' They got our money; however, we did learn a couple of things that allowed us to buy our first house for only $250 out of pocket,' says Jonathan, who had aspirations of becoming an illusionist à la David Copperfield. 'That's how we launched into it. Lo and behold, we were good at real estate.'
After about 10 years of flipping homes, Drew felt the pull of acting once again. 'I started getting host auditions as a real estate expert,' Drew says. At first, he dismissed the idea, hoping to be a film actor. But after talking with Jonathan, he reconsidered. 'We thought we could probably build a brand around this. We know how to design houses. What if we do what we were doing with clients locally for a larger national or global audience?' Soon after, Property Brothers launched in 2011 and became a top-rated HGTV staple. Other hit shows including Backed by the Bros and Buying and Selling followed. Ever entrepreneurial, the pair, who both now reside in Los Angeles, has become the largest home show producers in the country.
Building New Things
While the duo's audience may be most familiar with their on-air work, the Scott brothers are increasingly making a name for themselves in the world of retail products. Ten years ago, they launched their Scott Living and Drew & Jonathan Home brands, featuring an ever-growing collection of wallpaper, rugs, lighting, textiles, furniture and more. Since 2015, they've collaborated with licensing partners to create more than 12,000 unique SKUs for retailers from Amazon and Wayfair to Macy's and Rooms To Go. The term 'empire' isn't a stretch: as of early 2025, their products had netted more than $3 billion in retail sales.
It may be natural to assume that the more successful the Scotts become, the less they're getting their hands dirty. While they do have a capable team to assist, they're still in the thick of the real work that goes into transforming properties — the work that catapulted them to stardom in the first place. (On the day of our interview, Jonathan came in brushing sawdust off his shoulders, having raced over from a renovation project.)
It's also personal for them: They recently completed a project for their parents, who moved from their dream home in Banff, Canadato Los Angeles to be closer to the grandkids (Drew shares two kids with his wife, Linda, and Jonathan has two stepchildren with his fiancée, actress Zooey Deschanel). 'We had to make sure the house was everything they could ever want — that it was comfortable and that there were elements that made them feel the nostalgia of the mountains and the beauty of the rustic lifestyle,' Drew explains. 'It was a gut renovation of an 80-year-old Spanish style home in Santa Monica,' Jonathan says, finishing his brother's thought — a common occurrence. 'Nothing had ever been updated in the house, and it was in dire need of everything.' The project was documented for HGTV and the brothers shared behind-the-scenes insights on their YouTube channel. The result is a light-filled, functional house that has become a treasured home for the senior Scotts.
Good Work
Some made-for-television home renovation shows are plagued by rumors of shoddy craftsmanship and productions carting away décor and furniture when the filming stops. 'That would never work for a family in real life,' Drew says. 'I'm like, 'No, let's actually help families.' We've done 650 episodes or more of our shows (combined) now, and that's always been our philosophy. It's got to be done right whether a camera is there or not.'
That ethos of improving lives and giving back to the community flows through into their philanthropic endeavors as well. In 2017, the brothers were named Habitat Humanitarians, the highest recognition by Habitat for Humanity, and have led fundraisers and home builds across the country. Additionally, Jonathan sits on the board of electrification nonprofit Rewiring America and Drew sits on the board of The Environmental Media Association, an organization dedicated to encouraging more sustainable production. They also help in less public ways: During the devastating Los Angeles wildfires, Jonathan Deschanel offered their home to firefighters to use as a basecamp.
They feel like they're just getting started. In 2024, the Scott brothers partnered on a first-of-its-kind partnership called The Healthy Home Innovation Fund to invest in innovations that can help tackle the most pressing issues facing homeowners, renters, builders and others. The organization will help fund new ideas in smart home technologies, energy efficiency, digitization, safety and more.
No matter what new endeavor they dream up or project they tackle, the brothers are committed to working together, a lifetime habit. 'We've naturally fallen into this routine where we divide and conquer,' Jonathan says. 'Drew will run with one project. I'll run with another. It's almost seamless now. We don't even have to think about it. We call it twin telepathy.'
Follow along at drewandjonathan.com and at the newly launched Drew & Jonathan YouTube channel for behind-the-scenes show recaps, news about their product launches and tips for at-home DIY projects.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
3 hours ago
- Business Wire
Vitable Health Expands Care-Backed ICHRA Platform to Pennsylvania, Texas, and Florida Amid Rising Demand for SMB Health Benefits
PHILADELPHIA--(BUSINESS WIRE)-- Vitable Health, the leading all-in-one health benefits platform redefining care for the American workforce, today announced the availability of its care-backed ICHRA (Individual Coverage Health Reimbursement Arrangement) services in Pennsylvania, Texas, and Florida. This expansion follows the company's successful launch in Ohio and reflects growing demand from small businesses for health benefits that actually deliver care, not just coverage. As healthcare costs rise and small businesses continue to be left behind by traditional group insurance models, ICHRA adoption is accelerating across the country. New U.S. Census Bureau data, analyzed by BenefitsPro, shows that Florida and Texas are among the states with the highest uninsured rates, underscoring the urgent need for solutions that help employers close coverage gaps. According to the most recent HRA Council report, 83.5% of employers offering an ICHRA or QSEHRA did not provide any health benefits prior—a sign of the model's potential to expand access where it's needed most. 'Legislation will always lag behind reality,' said Joseph Kitonga, CEO of Vitable Health. 'This expansion is about more than geography, it's about proving that small businesses don't need to wait for lawmakers to fix the system. Affordable, high-quality healthcare for the working class isn't theoretical. It's here, it's working, and it's only the beginning.' In many of these markets, small businesses are facing what Vitable Health calls 'coverage deserts,' where traditional plans have become cost-prohibitive or inaccessible. By combining ICHRA administration with unlimited virtual primary care, preventive screenings, diagnostic lab panels, and zero-dollar prescriptions, Vitable removes the friction that typically keeps benefits and care siloed. This integrated model simplifies compliance for employers while improving health access and engagement for employees, particularly in industries like home health, construction, and hospitality, where coverage has historically been out of reach. In Pennsylvania, where Vitable Health is headquartered, this expansion marks the next stage of growth in the company's largest and most mature market. In Texas and Florida, two of the country's most challenging benefits environments, Vitable Health is helping employers deliver a competitive edge by pairing cost-efficient ICHRA benefits with real care. 'With Ohio's HB 133 and Indiana's HB 1004 setting the tone and ICHRA bills surfacing in other states, the message is clear: change is coming,' Kitonga added. 'The employers who act now aren't just getting ahead of the curve—they're leading it.' With this multi-state expansion, Vitable Health is demonstrating what a new standard for small-business health benefits looks like: affordable, accessible, and centered on real care rather than bureaucracy. To learn more about Vitable Health's ICHRA and primary care offerings for small businesses, visit Vitable Health is the nation's leading health benefits platform, making healthcare better for business owners and employees. With a focus on real access over red tape, Vitable Health offers employers affordable, ACA-compliant health benefit solutions, including Minimum Essential Coverage (MEC) plans, MVP plans, and ICHRA and QSEHRA options, that are packaged with Direct Primary Care and can be enhanced with Vision and Dental benefits. Every plan includes access to virtual primary care visits, mental health coaching, and over 1,000 covered prescriptions and labs with zero out-of-pocket costs. To date, Vitable Health has raised $25 million from top-tier investors, including First Round Capital, Y Combinator, Cherryrock Capital, Citi Bank's Impact Fund, Commerce Ventures, Jack Altman, Michael Seibel, Immad Akhund, and SoftBank Opportunity Fund.
Forbes
4 hours ago
- Forbes
Understanding Medical Liens: What CEOs Should Know
Mark Berookim is CEO & co-founder of High Rise Financial, a leader in pre-settlement legal funding and medical liens for plaintiffs. As CEOs, we're usually focused on big-picture goals such as growth, strategy and risk management. But when someone we work with, an employee or colleague, is seriously injured in an accident that was not their fault, it's the personal challenges that matter the most. In those moments, the support we offer can make a real difference. One of the most overlooked yet impactful tools available to individuals recovering from a personal injury is the medical lien. In my role leading a litigation funding company, I've seen firsthand how access to lien-based care can significantly improve both the physical outcome and long-term financial stability of plaintiffs. However, I've also seen how few people fully grasp what medical liens are and how to navigate them. Here's what CEOs should know: What A Medical Lien Is And Why It Matters To Business Leaders A medical lien is a legally binding agreement with a healthcare provider that allows a patient to receive full treatment without making any immediate payments. The hospital or medical practitioner agrees to be paid later from the settlement the plaintiff is expected to receive from their lawsuit. With this option, there is no burden of upfront costs and the healthcare provider is guaranteed payment once the case settles and receives compensation. By understanding how medical liens work, leaders can better support employees as they recover and navigate their legal claim. Personal injury cases often take months or even years to reach a settlement. During this time, plaintiffs might struggle to pay for necessary care and essential expenses. Without access to lien-based care, some employees might even delay or skip treatment because they are worried about the cost. This can slow down their recovery and make it harder for them to return to work. With the support of a medical lien, employees can focus on healing. Medical liens also help to foster a workplace culture that shows you care about your employees' well-being through every stage of their recovery. Things To Keep In Mind When Discussing Medical Liens If you're in a position to guide someone toward lien-based care, there are a few important nuances to keep in mind: Firstly, medical lien providers assess the strength of your case. Because repayment depends on a successful case outcome, healthcare providers will typically require confirmation that the plaintiff has legal representation and a case with merit. To avoid disappointment, your employee needs to understand that not all injuries or claims will qualify. Secondly, the final compensation is shared. Once the case is resolved, attorney fees, medical liens and any pre-settlement funding advances are deducted from the compensation. You need to ensure your employee understands these deductions so they are not caught off guard when the final amount is distributed. Practical Ways To Help Your Employees As a leader, you can't control the legal process, but you can help to create an environment that supports employees in their decision making. Here's how: Ensure your HR or benefits team has a go-to list of reputable legal and financial resources, such as attorneys, pre-settlement funding companies and medical lien providers. Having this ready means employees won't have to scramble to find help during a crisis. Create a space for employees to discuss their treatment options and timelines with HR or a wellness coordinator, especially if their injury affects their ability to work. Emphasizing the importance of getting care early, possibly through a medical lien, can lead to a faster recovery and better financial outcome. Most people don't even know that the option of a medical lien exists. It is up to you as a leader to ensure your employees are educated about their options. By hosting annual seminars or inviting representatives in the field to discuss medical liens and pre-settlement funding options, you can ensure your employees have the necessary knowledge to make an informed decision if the time comes. In the world of personal injuries, healing isn't just about surgery and physical therapy. It's also about peace of mind and knowing there is a path forward. Medical liens create a space for that peace of mind, even in the midst of legal and financial uncertainty. As CEOs, we're uniquely positioned to foster support systems that go beyond the surface. By understanding medical liens and how they fit into the broader picture of recovery, you can help ensure that your employees don't delay care, settle for less or carry more debt than they should. Being informed isn't just good leadership—it's a way to create meaningful impact in the lives of those around us. Forbes Business Council is the foremost growth and networking organization for business owners and leaders. Do I qualify?
Yahoo
4 hours ago
- Yahoo
Stock market today: Dow, S&P 500, Nasdaq futures climb as Wall Street digests July inflation report
US stock futures moved higher on Tuesday as Wall Street digested fresh inflation data and President Trump revealed his pick to head the Bureau of Labor Statistics. Futures attached to the Dow Jones Industrial Average (YM=F) rose 0.6%. Those tied to the benchmark S&P 500 (ES=F), and the tech-heavy Nasdaq 100 (NQ=F) were both up around 0.7%. The latest data from the Bureau of Labor Statistics showed that "core" inflation, which excludes volatile food and energy costs, rose 3.1% over the past year in July, ahead of June's 2.9% increase and indicating that rising goods inflation is no longer being offset by easing services inflation. But on a headline basis, the Consumer Price Index (CPI) increased 2.7% year-over-year, matching June and coming in softer than economist expectations of a 2.8% rise. The report was the first major piece of economic data to be released by the Bureau of Labor Statistics after Trump fired Erika McEntarfer as commissioner of the BLS earlier this month following the release of the July jobs report. Late Monday, Trump announced that he nominated E.J. Antoni, chief economist at the conservative Heritage Foundation, to lead the BLS. In corporate news, Intel (INTC) stock jumped more than 2% in premarket trading on Tuesday after CEO Lip-Bu Tan met with President Trump, who had called for Tan's resignation last week. After the meeting, Trump posted to Truth Social saying that he had met with Tan along with Secretary of Commerce Howard Lutnick and Secretary of the Treasury Scott Bessent. "The meeting was a very interesting one," the president wrote, adding, "His success and rise is an amazing story." On Tuesday, reports said China urged local firms not to use Nvidia H20 chips, complicating Trump's bid to turn those sales into a US windfall. Trump also granted another 90-day pause on the most punishing tariffs on China as the two countries work toward a trade deal. Read more: The latest on Trump's tariffs Investors will get two more pulse checks on the state of the economy later this week, with the release of the Producer Price Index on Thursday and retail sales data on Friday. "Core" price increases accelerate more than expected in July Price increases accelerated more than expected in July. The latest data from the Bureau of Labor Statistics showed that on a "core" basis, which strips out the more volatile costs of food and gas, consumer prices in increased 3.1% over the prior year in July, an increase from June's 2.9% and above economists' forecast for 3%. Core prices climbed 0.3% over the prior month, ahead of June's 0.2% increase but in line with expectations. The headline Consumer Price Index (CPI) showed prices increased 2.7% in July, unchanged from the month prior and below the 2.8% economists had expected. On a month-over-month basis, prices increased 0.2%, lower than the 0.3% seen the month prior. Circle stock jumps on first earnings report since going public Circle (CRCL) posted higher revenue and reserve income on Tuesday in its first quarterly report since its IPO in June, as circulation of its stablecoin USDC (USDC-USD) spread. Circle stock rose 6% in premarket trading on Tuesday. Its total gains since going public are now 133%. Reuters reports: Read more here. US small business optimism rebounds, but uncertainty clouds outlook Reuters reports: Read more here. Good morning. Here's what's happening today. Economic data: NFIB Small Business Optimism (July); Consumer Price Index (July); Real average hourly earnings (July) Earnings: Circle (CRCL), Pony AI (PONY), On Holding (ONON), CoreWeave (CRWV), Rigetti (RGTI), Cava (CAVA) Here are some of the biggest stories you may have missed overnight and early this morning: July inflation report expected to show prices accelerated Media musical chairs are reshaping the sports landscape Earnings live: Circle pops on higher revenue in first earnings report Intel stock rises after Trump praises CEO's 'amazing story' China urges firms to shun Nvidia chips, trade truce extended Musk accuses Apple of unfairly favoring OpenAI on iPhone Google and IBM believe workable quantum computer is in sight US small business optimism up but uncertainty clouds outlook Switzerland wants binding Trump commitment on gold tariffs Cannabis stocks soar as President Trump considers reclassifying marijuana Tilray (TLRY) stock rose another 10% in premarket trading on Tuesday after soaring 41% on Monday amid speculation that President Trump may move to reclassify marijuana as a less dangerous drug. The Canadian cannabis company traded hands at over $1 per share for the first time since February. Despite a 60% gain in the past month, however, shares are still off by 30% for the year. Other cannabis stocks saw a major lift as well. Trulieve (TCNNF) gained 38% on Monday, Curaleaf (CURLF) was up 35%, Green Thumb Industries (GTBIF) added 19%, Aurora (ACB) increased 16%, and Canopy Growth (CGC) surged 26%. On Friday, the Wall Street Journal reported that Trump told donors at a New Jersey fundraiser he was considering making marijuana a Schedule III drug, which would ease restrictions on the substance. Trump said he will make a final decision in the coming weeks. "We're looking at reclassification and we'll make a determination over the next — I would say over the next few weeks, and that determination hopefully will be the right one," Trump said. "It's a very complicated subject." Intel is still a disaster Intel (INTC) is rallying premarket as Trump walked back his apparent hate for the company's CEO, Lip-Bu Tan, after meeting on Monday. Don't be fooled by the price action, however. This isn't the case like Apple (AAPL), where CEO Tim Cook kisses Trump's butt and the company is exempt from various tariffs. Intel is a fundamental disaster right now. People in the industry I talk to are unsure if the company will ever come back to a state of health, given 1) how fast AI chip development is occurring, and 2) how far behind Nvidia and AMD Intel is. Intel's statement on the meeting: "Earlier today, Mr. Tan had the honor of meeting with President Trump for a candid and constructive discussion on Intel's commitment to strengthening U.S. technology and manufacturing leadership. We appreciate the President's strong leadership to advance these critical priorities and look forward to working closely with him and his Administration as we restore this great American company." Japan's Nikkei hits record high on tariff relief, tech rally The Nikkei 225 (^N225) hit a record high Tuesday as easing US tariff fears boosted optimism, led by tech stocks and tariff relief. Bloomberg News reports: Read more here. "Core" price increases accelerate more than expected in July Price increases accelerated more than expected in July. The latest data from the Bureau of Labor Statistics showed that on a "core" basis, which strips out the more volatile costs of food and gas, consumer prices in increased 3.1% over the prior year in July, an increase from June's 2.9% and above economists' forecast for 3%. Core prices climbed 0.3% over the prior month, ahead of June's 0.2% increase but in line with expectations. The headline Consumer Price Index (CPI) showed prices increased 2.7% in July, unchanged from the month prior and below the 2.8% economists had expected. On a month-over-month basis, prices increased 0.2%, lower than the 0.3% seen the month prior. Price increases accelerated more than expected in July. The latest data from the Bureau of Labor Statistics showed that on a "core" basis, which strips out the more volatile costs of food and gas, consumer prices in increased 3.1% over the prior year in July, an increase from June's 2.9% and above economists' forecast for 3%. Core prices climbed 0.3% over the prior month, ahead of June's 0.2% increase but in line with expectations. The headline Consumer Price Index (CPI) showed prices increased 2.7% in July, unchanged from the month prior and below the 2.8% economists had expected. On a month-over-month basis, prices increased 0.2%, lower than the 0.3% seen the month prior. Circle stock jumps on first earnings report since going public Circle (CRCL) posted higher revenue and reserve income on Tuesday in its first quarterly report since its IPO in June, as circulation of its stablecoin USDC (USDC-USD) spread. Circle stock rose 6% in premarket trading on Tuesday. Its total gains since going public are now 133%. Reuters reports: Read more here. Circle (CRCL) posted higher revenue and reserve income on Tuesday in its first quarterly report since its IPO in June, as circulation of its stablecoin USDC (USDC-USD) spread. Circle stock rose 6% in premarket trading on Tuesday. Its total gains since going public are now 133%. Reuters reports: Read more here. US small business optimism rebounds, but uncertainty clouds outlook Reuters reports: Read more here. Reuters reports: Read more here. Good morning. Here's what's happening today. Economic data: NFIB Small Business Optimism (July); Consumer Price Index (July); Real average hourly earnings (July) Earnings: Circle (CRCL), Pony AI (PONY), On Holding (ONON), CoreWeave (CRWV), Rigetti (RGTI), Cava (CAVA) Here are some of the biggest stories you may have missed overnight and early this morning: July inflation report expected to show prices accelerated Media musical chairs are reshaping the sports landscape Earnings live: Circle pops on higher revenue in first earnings report Intel stock rises after Trump praises CEO's 'amazing story' China urges firms to shun Nvidia chips, trade truce extended Musk accuses Apple of unfairly favoring OpenAI on iPhone Google and IBM believe workable quantum computer is in sight US small business optimism up but uncertainty clouds outlook Switzerland wants binding Trump commitment on gold tariffs Economic data: NFIB Small Business Optimism (July); Consumer Price Index (July); Real average hourly earnings (July) Earnings: Circle (CRCL), Pony AI (PONY), On Holding (ONON), CoreWeave (CRWV), Rigetti (RGTI), Cava (CAVA) Here are some of the biggest stories you may have missed overnight and early this morning: July inflation report expected to show prices accelerated Media musical chairs are reshaping the sports landscape Earnings live: Circle pops on higher revenue in first earnings report Intel stock rises after Trump praises CEO's 'amazing story' China urges firms to shun Nvidia chips, trade truce extended Musk accuses Apple of unfairly favoring OpenAI on iPhone Google and IBM believe workable quantum computer is in sight US small business optimism up but uncertainty clouds outlook Switzerland wants binding Trump commitment on gold tariffs Cannabis stocks soar as President Trump considers reclassifying marijuana Tilray (TLRY) stock rose another 10% in premarket trading on Tuesday after soaring 41% on Monday amid speculation that President Trump may move to reclassify marijuana as a less dangerous drug. The Canadian cannabis company traded hands at over $1 per share for the first time since February. Despite a 60% gain in the past month, however, shares are still off by 30% for the year. Other cannabis stocks saw a major lift as well. Trulieve (TCNNF) gained 38% on Monday, Curaleaf (CURLF) was up 35%, Green Thumb Industries (GTBIF) added 19%, Aurora (ACB) increased 16%, and Canopy Growth (CGC) surged 26%. On Friday, the Wall Street Journal reported that Trump told donors at a New Jersey fundraiser he was considering making marijuana a Schedule III drug, which would ease restrictions on the substance. Trump said he will make a final decision in the coming weeks. "We're looking at reclassification and we'll make a determination over the next — I would say over the next few weeks, and that determination hopefully will be the right one," Trump said. "It's a very complicated subject." Tilray (TLRY) stock rose another 10% in premarket trading on Tuesday after soaring 41% on Monday amid speculation that President Trump may move to reclassify marijuana as a less dangerous drug. The Canadian cannabis company traded hands at over $1 per share for the first time since February. Despite a 60% gain in the past month, however, shares are still off by 30% for the year. Other cannabis stocks saw a major lift as well. Trulieve (TCNNF) gained 38% on Monday, Curaleaf (CURLF) was up 35%, Green Thumb Industries (GTBIF) added 19%, Aurora (ACB) increased 16%, and Canopy Growth (CGC) surged 26%. On Friday, the Wall Street Journal reported that Trump told donors at a New Jersey fundraiser he was considering making marijuana a Schedule III drug, which would ease restrictions on the substance. Trump said he will make a final decision in the coming weeks. "We're looking at reclassification and we'll make a determination over the next — I would say over the next few weeks, and that determination hopefully will be the right one," Trump said. "It's a very complicated subject." Intel is still a disaster Intel (INTC) is rallying premarket as Trump walked back his apparent hate for the company's CEO, Lip-Bu Tan, after meeting on Monday. Don't be fooled by the price action, however. This isn't the case like Apple (AAPL), where CEO Tim Cook kisses Trump's butt and the company is exempt from various tariffs. Intel is a fundamental disaster right now. People in the industry I talk to are unsure if the company will ever come back to a state of health, given 1) how fast AI chip development is occurring, and 2) how far behind Nvidia and AMD Intel is. Intel's statement on the meeting: "Earlier today, Mr. Tan had the honor of meeting with President Trump for a candid and constructive discussion on Intel's commitment to strengthening U.S. technology and manufacturing leadership. We appreciate the President's strong leadership to advance these critical priorities and look forward to working closely with him and his Administration as we restore this great American company." Intel (INTC) is rallying premarket as Trump walked back his apparent hate for the company's CEO, Lip-Bu Tan, after meeting on Monday. Don't be fooled by the price action, however. This isn't the case like Apple (AAPL), where CEO Tim Cook kisses Trump's butt and the company is exempt from various tariffs. Intel is a fundamental disaster right now. People in the industry I talk to are unsure if the company will ever come back to a state of health, given 1) how fast AI chip development is occurring, and 2) how far behind Nvidia and AMD Intel is. Intel's statement on the meeting: "Earlier today, Mr. Tan had the honor of meeting with President Trump for a candid and constructive discussion on Intel's commitment to strengthening U.S. technology and manufacturing leadership. We appreciate the President's strong leadership to advance these critical priorities and look forward to working closely with him and his Administration as we restore this great American company." Japan's Nikkei hits record high on tariff relief, tech rally The Nikkei 225 (^N225) hit a record high Tuesday as easing US tariff fears boosted optimism, led by tech stocks and tariff relief. Bloomberg News reports: Read more here. The Nikkei 225 (^N225) hit a record high Tuesday as easing US tariff fears boosted optimism, led by tech stocks and tariff relief. Bloomberg News reports: Read more here.
